Did you already set up your mind about plasma therapy for COVID-19? | RAMPmedical News

In particular, there were 2 studies showing the opposite:

The 1st study shows a positive outcome for patients:

"Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience"

https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1


The 2nd study shows even a worsening:

"Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)"

https://www.medrxiv.org/content/10.1101/2020.09.03.20187252v1.full.pdf


As usual, we looked into the studies, and found that there is not only a different outcome, but also a mentionable difference in when the therapy had been applied. Emphasizing that the evidence is low regarding all treatments for COVID-19, in comparison to all available treatments, the early application of plasma therapy seems quite promising.


For details of our analysis regarding the efficacy and safety of the treatments for COVID-19, you can REGISTER under rampmedical.com. EU-awarded and free access.


RAMPmedical software

RAMPmedical

Henisaja GmbH

 

Kastanienallee 61

10119 Berlin

​info@rampmedical.com

Chief Executive Officer:  Helene Schönewolf

+49 (0) 30 31 98 08 52​

Registered at the local court Berlin Charlottenburg HRB 167143 B

VAT: DE299921795

Follow us

Twitter_Social_Icon_Circle_White-01.png
f_logo_RGB-White_100.png

Copyright 2020 | RAMPmedical